2017
Risk/Benefit Discussion of Alcohol Use Disorder Medications: Behavioral Economic Considerations and General Recommendations
Santana T, Greenwald M, Rosen M. Risk/Benefit Discussion of Alcohol Use Disorder Medications: Behavioral Economic Considerations and General Recommendations. Journal Of Addiction Research & Therapy 2017, 8: 1-8. DOI: 10.4172/2155-6105.1000315.Peer-Reviewed Original ResearchRisk/benefit discussionAlcohol use disorderAUD medicationsBenefit discussionInteroceptive effectsAlcohol use disorder medicationsAlcohol useBehavioral economic principlesRisk/benefitReduced alcohol usePrescribers' practicesMedication risksEffective medicationsPatients' perceptionsPatient acceptanceMedicationsUse disordersCognitive dissonancePatientsPsychological stateNarrative thinkingBiased decisionsRiskHalo effectFormulation of guidelines
1996
Effect of clonidine pretreatment on naloxone-precipitated opiate withdrawal.
Rosen M, McMahon T, Hameedi F, Pearsall H, Woods S, Kreek M, Kosten T. Effect of clonidine pretreatment on naloxone-precipitated opiate withdrawal. Journal Of Pharmacology And Experimental Therapeutics 1996, 276: 1128-35. PMID: 8786543.Peer-Reviewed Original ResearchConceptsClonidine pretreatmentOpiate withdrawalAdrenocorticotropic hormone (ACTH) responseDiastolic blood pressureNaloxone-precipitated opiate withdrawalNaloxone challenge testHeroin-dependent subjectsMeasures of withdrawalNasal congestionBlood pressureNew medicationsWithdrawal severityTesting medicationsChallenge testPlasma cortisolHormone responseConsecutive daysPilot studyClonidineMedicationsPositive controlWithdrawalBase linePretreatmentTwo-factor analysis